STAT3 Inhibition in Prostate and Pancreatic Cancer Lines by STAT3 Binding Sequence Oligonucleotides: Differential Activity Between 5' and 3' Ends

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-08-0154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Scoparone Exerts Anti-Tumor Activity Against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity

PLoS ONE
Multidisciplinary
2013English

Stat3 Promotes Metastatic Progression of Prostate Cancer

American Journal of Pathology
Forensic MedicinePathology
2008English

Crizotinib Induces Autophagy Through Inhibition of the STAT3 Pathway in Multiple Lung Cancer Cell Lines

Oncotarget
Oncology
2015English

Dimer Stability as a Determinant of Differential DNA Binding Activity of Stat3 Isoforms

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Isolinderalactone Enhances the Inhibition of SOCS3 on STAT3 Activity by Decreasing miR-30c in Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2015English

STAT3 and STAT5A Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer

Oncotarget
Oncology
2017English

Loss-Of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer

PLoS ONE
Multidisciplinary
2015English

Development of a Combination Therapy for Prostate Cancer by Targeting Stat3 and HIF-1alpha

2013English

HDAC8 and STAT3 Repress BMF Gene Activity in Colon Cancer Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy